A researcher at University of Oklahoma’s Stephenson Cancer Center is leading a global trial for a promising new treatment for ovarian cancer.The recent clinical
Ovarian cancer drug RC88 by RemeGen received FDA approval for Phase 2 clinical trials. Gynecologic oncologist Dr. Brian Slomovitz and other experts weigh in on the drug's potential.
Researchers at OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences have embarked on a revolutionary new research study that could improve the detection of a deadly disease -; pancreatic cancer -; and give patients a chance to live longer, healthier lives.
Ovarian cancer treatment on fast track for FDA approval as chemo alternatives emerge: 'We're making progress' yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Ovarian cancer treatment on fast track for FDA approval as chemo alternatives emerge: 'We're making progress' wfin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wfin.com Daily Mail and Mail on Sunday newspapers.